Difference between revisions of "Team:SJTU-BioX-Shanghai/Loader"

Line 132: Line 132:
 
</ul>
 
</ul>
 
<!--*********************** list-elements template ends ***********************-->
 
<!--*********************** list-elements template ends ***********************-->
<p>More about our<a title="interview with Roche" href="https://2018.igem.org/Team:SJTU-BioX-Shanghai/Human_Practices">interview with Roche</a>.
+
<p>More about our <a title="interview with Roche" href="https://2018.igem.org/Team:SJTU-BioX-Shanghai/Human_Practices">interview with Roche</a>.
 
</p>
 
</p>
  

Revision as of 19:46, 17 October 2018

Loader

In spite of test in vitro and in vivo, we also took our first step to make ECHO a real product.

ECHO Capsules

After we visited Roche with Tongji_China, we have been thinking about the proper load of ECHO. In our interview with Lingjie Zhou, who is responsible for quality assurance in Roche, she talked about the advantage of capsules compared with other pharmaceutical preparations, which are listed below.

  • High bioavailability
  • Reliable stability
  • Flexible form
  • Good compliance of patients
  • Easy manufacture

More about our interview with Roche.

After the visit, we decided to collaborate with Tongji_China, to purchase the enteric capsule, DRcaps, from Capsugel, a global pharmaceutical dosage solutions company. This kind of capsule can protect product ingredients form stomach acid so that it can release ECHO in colon where our device is supposed to function. You can find the ECHO capsules protocol at the protocolpage.